Chimeric share price
WebJan 18, 2024 · Chimeric Therapeutics’ IPO was priced at 20 cents per share. At 11am shares opened at 36 cents – representing an 80 per cent gain. This makes Chimeric by far the ASX’s most successful IPO so far in 2024 albeit only the fourth new listing this year. Chimeric Therapeutics (ASX:CHM) share price chart Web80.52 -0.03(-0.04%) Gold 1,787.00 +27.10(+1.54%) Chimeric Therapeutics Limited (CHM.AX) ASX - ASX Delayed Price. Currency in AUD Follow 0.0810 -0.0020 (-2.41%) As of 12:18PM AEDT. Market open....
Chimeric share price
Did you know?
WebMar 23, 2024 · Chimerix stock price target cut to $6 from $20 at Maxim Group May. 17, 2024 at 7:47 a.m. ET by Tomi Kilgore Chimerix stock … WebFeb 15, 2024 · Chimeric sought – and banked – $35 million in its initial public offer, but returned the cheques to investors, who are further seeking another $60 million. Given the unrequited demand, we shouldn’t be surprised the 20 …
WebApr 11, 2024 · HotCopper has news, discussion, prices and market data on CHIMERIC THERAPEUTICS LIMITED. Join the HotCopper ASX share market forum today for free. WebNasdaqGS - NasdaqGS Real-time price. Currency in USD Add to watchlist 56.47 +0.54 (+0.97%) At close: 04:00PM EDT 56.27 -0.20 (-0.35%) After hours: 07:56PM EDT 1d 5d …
Web9 rows · CHM Historical Price Data (CSV) Up to 20 years of EOD share price history. Sign up to ... WebFeb 7, 2024 · Chimeric Antibody Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2028 - MarketWatch Feb 07, 2024 (The Expresswire) -- "Chimeric Antibody Market" Size,...
WebChimeric Therapeutics share price volatility. Over the last 12 months, Chimeric Therapeutics's shares have ranged in value from as little as $0.064 up to $0.17. A popular way to gauge a stock's ...
WebSep 3, 2024 · Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. ... Valuation at 93 cents per share. March 2024 RAAS Report: Entitlement Offer to Raise up to $18.1m. March 2024 Diamond Equity Research Update Note 28 Feb 2024 ... Historical Price Lookup ... shanghai film groupWebJan 23, 2024 · Price trends tend to persist, so it's worth looking at them when it comes to a share like Chimeric Therapeutics. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by-43.57%. As of the last closing price of AU$0.07, shares in Chimeric Therapeutics were trading-26.1% below their 200 shanghai finance bureauWebSep 3, 2024 · Diamond Equity Research Updates Valuation at 71 cents per share. August 2024. Diamond Equity Research Update. Positive Momentum Continues as Pipeline … shanghai film group corporationWebMay 24, 2024 · At market’s close, the Chimeric share price was trading at 29 cents, down 3.33%. Established in 2024, Chimeric is developing a breakthrough cancer cell therapy … shanghai film festival 2022WebInformation on stock, financials, earnings, subsidiaries, investors, and executives for Chimeric Therapeutics. Use the PitchBook Platform to explore the full profile. Information on stock, financials, earnings, subsidiaries, investors, and executives for Chimeric Therapeutics. ... Share Price; $0.05 (As of Monday Closing) ... Stock Price ... shanghai fimet medical instrument co. ltdWebDiscover historical prices for CHM.AX stock on Yahoo Finance. View daily, weekly or monthly format back to when Chimeric Therapeutics Limited stock was issued. shanghai film studioWeb2,000.70 +14.50(+0.73%) Chimeric Therapeutics Limited (CHM.AX) ASX - ASX Delayed Price. Currency in AUD Follow 0.0600 +0.0010 (+1.69%) At close: 04:10PM AEST 1d 5d 1m 6m YTD 1y 5y Max Full... shanghai finance court